Real-time enrollment status for this immune thrombocytopenia clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 3:43 PM UTC
| NCT Number | NCT06721013 |
| Recruiting Status | Recruiting |
| Condition | Immune Thrombocytopenia |
| Phase | PHASE1 |
| Target Enrollment | 68 participants |
| Active Locations | 11 sites in the US |
| Sponsor | Eli Lilly and Company |
| Last Updated on CT.gov | June 25, 2026 (3 weeks ago) |
As of July 18, 2026: Clinical trial NCT06721013 is currently recruiting participants. This phase1 study for immune thrombocytopenia is actively seeking new participants at 11 locations across the United States. The study is sponsored by Eli Lilly and Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06721013 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06721013 was last updated 3 weeks ago (June 25, 2026). HelloStudys verifies this status automatically.